Gal-8’s role in MS, an autoimmune inflammatory disease of the CNS, remains unknown.[6] Gal-8 is a heterodimer with an N-terminal carbohydrate recognition domain and a C-terminal carbohydrate recognition domain. This evidence concerns the gene LGALS8 and myeloid sarcoma.